BioSpace News Archive

Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, today announced the appointment of Todd Bazemore , a biopharmaceutical executive with significant experience in res

Field Trip Psychedelics Inc. (“Field Trip”), the company redefining mental health and well-being through its ground-breaking work in psychedelics and psychedelic-enhanced psychotherapy, has successfully completed GLP (Good Laboratory Practices) synthesis of its first molecule in development, FT-104.

Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that it has entered into an accelerated second phase of its collaboration with a large pharmaceutical company to tailor its high-throughput pharmacokinetic (HTPK) simulation functionality within ADMET Predictor®

Hepion Pharmaceuticals, Inc. today announced that Dr. Robert Foster, will present virtually at the H.C. Wainwright 4 th Annual NASH Conference on Monday, October 5, 2020 at 4:00 p.m. E.T.

CMA physician survey also highlights concerns about availability of flu vaccine and physicians’ capacity to provide it, with demand exceeding supply

Confirm BioSciences, a leading provider of comprehensive medical screening tools and solutions, and Securiport, a global leader in the design and implementation of civil aviation security, border management, advanced identification, and threat assessment systems, announced today that the companies have partnered to offer Confirm BioSciences’ rapid COVID-19 testing kits through Securiport’s Epidemic Control System (ECS).

The Muscular Dystrophy Association (MDA) announced today MDA Let’s Play For A Cure, a multi-week streaming event to drive awareness and fundraising for MDA

US Oncology Research, one of the largest community-based oncology research site management organizations in the U.S., is celebrating the significant milestone of contributing to the FDA approval of over 100 cancer therapies

IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSXV: IPA) (OTCQB: IPATF) today announced financial results for its fiscal year 2021 first quarter ended July 31, 2020.

IgGenix, Inc, today congratulated co-founder Kari Nadeau, M.D., Ph.D., and her co-author, Sloan Barnett, on the publication of their book ‘ The End of Food Allergy’, a seminal work detailing the prevention, diagnosis and reversal of food allergies, with insight into the future of allergy treatment and therapies. Food allergy is a